0001724521-24-000112.txt : 20240607
0001724521-24-000112.hdr.sgml : 20240607
20240607182021
ACCESSION NUMBER: 0001724521-24-000112
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240606
FILED AS OF DATE: 20240607
DATE AS OF CHANGE: 20240607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PERLMAN ANDREW J
CENTRAL INDEX KEY: 0001201617
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38419
FILM NUMBER: 241031020
MAIL ADDRESS:
STREET 1: 618 MIRADA AVE
CITY: STANFORD
STATE: CA
ZIP: 94305
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arcus Biosciences, Inc.
CENTRAL INDEX KEY: 0001724521
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 473898435
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3928 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
BUSINESS PHONE: (510) 694-6200
MAIL ADDRESS:
STREET 1: 3928 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
4
1
wk-form4_1717798812.xml
FORM 4
X0508
4
2024-06-06
0
0001724521
Arcus Biosciences, Inc.
RCUS
0001201617
PERLMAN ANDREW J
C/O ARCUS BIOSCIENCES, INC.
3928 POINT EDEN WAY
HAYWARD
CA
94545
1
0
0
0
0
Common Stock
2024-06-06
4
A
0
8400
0
A
29325
D
Stock Option (Right to Buy)
15.90
2024-06-06
4
A
0
24000
0
A
2034-06-05
Common Stock
24000
24000
D
Represents the grant of restricted stock units that vest in full on the earlier of June 6, 2025 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.
The option will vest in full on the earlier of June 6, 2025 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control.
/s/ Carolyn Tang, Attorney-in-Fact
2024-06-07